Beta-endorphin (2.5 mg IV bolus) administered to non-insulin dependent individuals with T2D resulted in increased plasma levels of insulin at 90 min with a decrease in plasma glucose [40]. This evidence concerns the gene INS and type 2 diabetes mellitus.